Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer

Zainab Hussain,Thomas Bertran,Pascal Finetti,Eugenie Lohmann,Emilie Mamessier,Ghislain Bidaut,François Bertucci,Moacyr Rego,Richard Tomasini

DOI: https://doi.org/10.1186/s12964-023-01388-7

IF: 7.525

2024-01-04

Cell Communication and Signaling

Abstract:Pancreatic ductal adenocarcinoma (PDAC) remains a clinically challenging cancer, mainly due to limited therapeutic options and the presence of a highly prominent tumor microenvironment (TME), facilitating tumor progression. The TME is predominated by heterogeneous populations of cancer-associated fibroblasts (CAFs) and tumor associated macrophages (TAMs), in constant communication with each other and with tumor cells, influencing many tumoral abilities such as therapeutic resistance. However how the crosstalk between CAFs and macrophages evolves following chemotherapeutic treatment remains poorly understood, limiting our capacity to halt therapeutic resistance.

cell biology